Kessler Topaz Meltzer & Check, LLP: Investigation on Behalf of InnovAge Holding Corp. Shareholders

Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of InnovAge Holding Corp. (NASDAQ: INNV) (“InnovAge”) securities pursuant to the company's intial public offering on or around March 3, 2021.

InnovAge investors may receive additional information about the investigation by clicking the link "Submit Your Information" above.

InnovAge manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities.

On September 21, 2021, after the market closed, certain InnovAge executive officers participated in an earnings conference call. During the conference call, Maureen Hewitt, InnovAge’s president and Chief Executive Officer, revealed that the Centers for Medicare and Medicaid Services had “determined to freeze new enrollments at [InnovAge’s] Sacramento center based on deficiencies detected in [a May 2021] audit.” Ms. Hewitt stated that these “deficiencies relate to failures to provide covered services, provide accessible and adequate services, manage participants’ medical situations, and oversee use of specialists, among others.”

Following this news, InnovAge’s stock price fell $2.90, or nearly 25%, to close at $8.75 per share on September 22, 2021.

If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP:  James Maro, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at [email protected].